Cargando…

Point-of-sale marketing of heated tobacco products in Israel: cause for concern

Understanding how PMI markets IQOS at the point-of-sale in Israel is critical to determining whether marketing practices adhere to regulations and appeal to groups most at risk at initiating new tobacco products, such as adolescents. An article by Bar-Zev, Levine, Rubinstein, Khateb, and Berg (2019)...

Descripción completa

Detalles Bibliográficos
Autor principal: Halpern-Felsher, Bonnie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535843/
https://www.ncbi.nlm.nih.gov/pubmed/31133053
http://dx.doi.org/10.1186/s13584-019-0316-6
_version_ 1783421646587035648
author Halpern-Felsher, Bonnie
author_facet Halpern-Felsher, Bonnie
author_sort Halpern-Felsher, Bonnie
collection PubMed
description Understanding how PMI markets IQOS at the point-of-sale in Israel is critical to determining whether marketing practices adhere to regulations and appeal to groups most at risk at initiating new tobacco products, such as adolescents. An article by Bar-Zev, Levine, Rubinstein, Khateb, and Berg (2019) examined the marketing of IQOS in retail stores in Israel. They found that while no free samples or promotions were provided at the point-of-sale, IQOS and their related HEETS (HeatSticks) were placed near youth-oriented merchandise and in prominent locations easily seen by youth. Further, package colors were used to indicate tobacco flavorings and strength, and retailers described the IQOS products as being less harmful, a cessation device, and not producing smoke. These findings are concerning given numerous studies linking marketing of novel tobacco products, product misperceptions, and subsequent tobacco use. Studies are needed to ensure that the marketing of IQOS, including the use of package colors, product placement at point-of-sales, and other product characteristics are significantly reducing harm and risk of tobacco-related disease to IQOS users, and that the health of the population as a whole, including those not using IQOS or other tobacco products, will not be harmed. Until such evidence is available, caution is warranted and regulations needed in the marketing of these novel products.
format Online
Article
Text
id pubmed-6535843
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65358432019-05-30 Point-of-sale marketing of heated tobacco products in Israel: cause for concern Halpern-Felsher, Bonnie Isr J Health Policy Res Commentary Understanding how PMI markets IQOS at the point-of-sale in Israel is critical to determining whether marketing practices adhere to regulations and appeal to groups most at risk at initiating new tobacco products, such as adolescents. An article by Bar-Zev, Levine, Rubinstein, Khateb, and Berg (2019) examined the marketing of IQOS in retail stores in Israel. They found that while no free samples or promotions were provided at the point-of-sale, IQOS and their related HEETS (HeatSticks) were placed near youth-oriented merchandise and in prominent locations easily seen by youth. Further, package colors were used to indicate tobacco flavorings and strength, and retailers described the IQOS products as being less harmful, a cessation device, and not producing smoke. These findings are concerning given numerous studies linking marketing of novel tobacco products, product misperceptions, and subsequent tobacco use. Studies are needed to ensure that the marketing of IQOS, including the use of package colors, product placement at point-of-sales, and other product characteristics are significantly reducing harm and risk of tobacco-related disease to IQOS users, and that the health of the population as a whole, including those not using IQOS or other tobacco products, will not be harmed. Until such evidence is available, caution is warranted and regulations needed in the marketing of these novel products. BioMed Central 2019-05-27 /pmc/articles/PMC6535843/ /pubmed/31133053 http://dx.doi.org/10.1186/s13584-019-0316-6 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Halpern-Felsher, Bonnie
Point-of-sale marketing of heated tobacco products in Israel: cause for concern
title Point-of-sale marketing of heated tobacco products in Israel: cause for concern
title_full Point-of-sale marketing of heated tobacco products in Israel: cause for concern
title_fullStr Point-of-sale marketing of heated tobacco products in Israel: cause for concern
title_full_unstemmed Point-of-sale marketing of heated tobacco products in Israel: cause for concern
title_short Point-of-sale marketing of heated tobacco products in Israel: cause for concern
title_sort point-of-sale marketing of heated tobacco products in israel: cause for concern
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535843/
https://www.ncbi.nlm.nih.gov/pubmed/31133053
http://dx.doi.org/10.1186/s13584-019-0316-6
work_keys_str_mv AT halpernfelsherbonnie pointofsalemarketingofheatedtobaccoproductsinisraelcauseforconcern